60 DEGREES PHARMACEUTICALS, INC. (SXTPW)
2025-06-30 | ||||
---|---|---|---|---|
Product revenues net of discounts and rebates | 100,932 | |||
Cost of revenues | 50,051 | |||
Gross profit | 50,881 | |||
Research revenues | 206,939 | |||
Net revenue | 257,820 | |||
Research and development | 249,884 | |||
General and administrative expenses | 1,612,764 | |||
Total operating expenses | 1,862,648 | |||
Loss from operations | -1,604,828 | |||
Other income, net | 13,066 | |||
Interest expense | 1,221 | |||
Change in fair value of derivative liabilities | 140,447 | |||
Total interest and other (expense) income, net | -128,602 | |||
Loss from operations before provision for income taxes | -1,733,430 | |||
Provision for income taxes (note 9) | 1,500 | |||
Net loss | -1,734,930 | |||
Net loss noncontrolling interest | -1,204 | |||
Net loss attributed to 60 degrees pharmaceuticals, inc | -1,733,726 | |||
Basic (in dollars per share) | -1.25 | |||
Basic (in shares) | 1,472,891 | |||
Diluted (in dollars per share) | -1.25 | |||
Diluted (in shares) | 1,472,891 |